Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 101 of 1,261
  1. US 12060327

    Psychotropic agents and uses thereof

    LB PHARMACEUTICALS INC. · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  2. US 12060428

    Anti-IL36R antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  3. US 12060398

    Fibrous proteinaceous networks and methods of use thereof

    Northwestern University · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  4. US 12060382

    Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole

    Takeda Pharmaceutical Company Limited · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  5. US 12060362

    Inhibitors of glucose transporters (GLUTs)

    Lead Discovery Center GmbH · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  6. US 12059407

    Compositions and methods for delivery of macromolecules

    The Regents of the University of California · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  7. US 12059468

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  8. US 12060350

    Therapeutic compounds and methods of use thereof

    Regents of the University of Minnesota · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  9. US 12059443

    Method for treating cancer using dengue virus serotype 1 (DENV-1)

    PrimeVax Immuno-Oncology · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  10. US 12059418

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  11. US 12059400

    Medical compound

    VERA SALUS RICERCA S.R.L. · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  12. US 12059477

    Nanomaterials

    Beam Therapeutics Inc. · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  13. US 12059413

    Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  14. WO 2024162304

    LIPIDE CARBAMOYLE OU LIPIDE D'URÉE AYANT CHACUN UNE AMINE CYCLIQUE, NANOPARTICULES LIPIDIQUES LE CONTENANT ET COMPOSITION PHARMACEUTIQUE

    ASTELLAS PHARMA INC [JP] · Granted Aug 8, 2024 · Expires Aug 3, 2044

    granted
  15. US 12054483

    Small molecule inhibitors of DYRK/CLK and uses thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  16. US 12053531

    Materials and methods for treatment of Duchenne Muscular Dystrophy

    Vertex Pharmaceuticals Incorporated · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  17. US 12054519

    Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  18. US 12054533

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  19. US 12054556

    Anti-PD-L1 antibody and use thereof

    Oricell Therapeutics Co., Ltd. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  20. US 12054553

    Immunotherapeutic tumor treatment method

    Nektar Therapeutics · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  21. US 12054537

    Optimized nucleic acid antibody constructs encoding anti-respiratory syncytial virus (RSV) antibodies

    Inovio Pharmaceuticals, Inc. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  22. US 12054501

    Compositions and methods for inhibiting arginase activity

    Precision Pharmaceuticals, Inc. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  23. US 12054509

    Antimicrobial compounds, compositions, and uses thereof

    Lakewood Amedex, Inc. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  24. US 12054500

    Arginase inhibitors

    Arcus Biosciences, Inc. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.